RNA interference silencing of DRAL affects processing of amyloid precursor protein

Neuroscience Letters

Volumn 439, Issue 3, 2008, Pages 293-297

  Tanahashi, Hiroshi ^a   Yoshioka, Katsuji ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Secretase; ADAM 10 Kuzbanian; ADAM 17 TACE; Alzheimer's disease; Amyloid precursor protein (APP); DRAL FHL2 SLIM3

Indexed keywords

ALPHA SECRETASE; AMYLOID BETA PROTEIN[25-35]; AMYLOID PRECURSOR PROTEIN; DISINTEGRIN; PROTEIN P53; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL STRAIN COS7; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN SECRETION; RNA INTERFERENCE;

ADAM PROTEINS; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; CELL LINE, TRANSFORMED; CERCOPITHECUS AETHIOPS; CRICETINAE; HOMEODOMAIN PROTEINS; HUMANS; MEMBRANE PROTEINS; MUSCLE PROTEINS; PHORBOL ESTERS; PROSTANOIC ACIDS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 44649149519     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2008.05.039     Document Type: Article

References (14)

1. Allinson T.M., Parkin E.T., Turner A.J., and Hooper N.M. ADAMs family members as amyloid precursor protein α-secretases. J. Neurosci. Res. 74 (2003) 342-352
2. Askanas V., and Engel W.K. Inclusion-body myositis: a myodegenerative conformational disorder associated with Aβ, protein misfolding, and proteasome inhibition. Neurology 66 (2006) S39-S48
3. Bensadoun A., and Weinstein D. Assay of proteins in the presence of interfering materials. Anal. Biochem. 70 (1976) 241-250
4. Buxbaum J.D., Liu K.N., Slack J.L., Stocking K.L., Peschon J.J., Johnson R.S., Castner B.J., Cerretti D.P., and Black R.A. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273 (1998) 27765-27767
5. Canault M., Tellier E., Bonardo B., Mas E., Aumailley M., Juhan-Vague I., Nalbone G., and Peiretti F. FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity. J. Cell. Physiol. 208 (2006) 363-372
6. Haass C. Take five-BACE and the γ-secretase quartet conduct Alzheimer's amyloid β-peptide generation. EMBO J. 23 (2004) 483-488
7. Johannessen M., Moller S., Hansen T., Moens U., and Van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell Mol. Life Sci. 63 (2006) 268-284
8. Kleiber K., Strebhardt K., and Martin B.T. The biological relevance of FHL2 in tumor cells and its role as a putative cancer target. Anticancer Res. 27 (2007) 55-61
9. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haas C., and Fahrenholz F. Constitutive and regulated α-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 3922-3927
10. Morlon A., and Sassone-Corsi P. The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 3977-3982
11. Mourabit H.E., Muller S., Tunggal L., Paulsson M., and Aumailley M. Analysis of the adaptor function of the LIM domain-containing protein FHL2 using an affinity chromatography approach. J. Cell. Biochem. 92 (2004) 612-625
12. Scholl F.A., McLoughlin P., Ehler E., de Giovanni C., and Schafer B.W. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J. Cell. Biol. 151 (2000) 495-505
13. Tanahashi H., and Tabira T. Alzheimer's disease-associated presenilin 2 interacts with DRAL, an LIM-domain protein. Hum. Mol. Genet. 9 (2000) 2281-2289
14. Tanahashi H., and Tabira T. Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production. Neurosci. Lett. 307 (2001) 9-12